A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma (Q34992535)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma |
scientific article |
Statements
1 reference
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma (English)
1 reference
Mark R Gilbert
1 reference
Javier Gonzalez
1 reference
Kathy Hunter
1 reference
Kenneth Hess
1 reference
Pierre Giglio
1 reference
Eric Chang
1 reference
Vinay Puduvalli
1 reference
Morris D Groves
1 reference
Howard Colman
1 reference
Charles Conrad
1 reference
Victor Levin
1 reference
Shaio Woo
1 reference
Anita Mahajan
1 reference
John de Groot
1 reference
W K Alfred Yung
1 reference
20 August 2010
1 reference
1 reference
4 October 2016
1 reference
Identifiers
1 reference